HK1223108A1 - 用羥基磷灰石層析分離雙特異性抗體和雙特異性抗體生產副產物 - Google Patents
用羥基磷灰石層析分離雙特異性抗體和雙特異性抗體生產副產物Info
- Publication number
- HK1223108A1 HK1223108A1 HK16111307.7A HK16111307A HK1223108A1 HK 1223108 A1 HK1223108 A1 HK 1223108A1 HK 16111307 A HK16111307 A HK 16111307A HK 1223108 A1 HK1223108 A1 HK 1223108A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- separation
- antibody production
- bispecific
- side products
- production side
- Prior art date
Links
- 239000006227 byproduct Substances 0.000 title 1
- 238000004587 chromatography analysis Methods 0.000 title 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 title 1
- 230000016784 immunoglobulin production Effects 0.000 title 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title 1
- 238000000926 separation method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/18—Ion-exchange chromatography
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/36—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
- B01D15/361—Ion-exchange
- B01D15/362—Cation-exchange
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
- B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
- B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
- B01D15/3804—Affinity chromatography
- B01D15/3809—Affinity chromatography of the antigen-antibody type, e.g. protein A, G, L chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2875—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF/TNF superfamily, e.g. CD70, CD95L, CD153, CD154
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/46—Hybrid immunoglobulins
- C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/51—Complete heavy chain or Fd fragment, i.e. VH + CH1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/66—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising a swap of domains, e.g. CH3-CH2, VH-CL or VL-CH1
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13180912 | 2013-08-19 | ||
PCT/EP2014/067552 WO2015024896A1 (en) | 2013-08-19 | 2014-08-18 | Separation of bispecific antibodies and bispecific antibody production side products using hydroxyapatite chromatography |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1223108A1 true HK1223108A1 (zh) | 2017-07-21 |
Family
ID=48985686
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16111307.7A HK1223108A1 (zh) | 2013-08-19 | 2016-09-27 | 用羥基磷灰石層析分離雙特異性抗體和雙特異性抗體生產副產物 |
Country Status (11)
Country | Link |
---|---|
US (1) | US10316059B2 (zh) |
EP (1) | EP3036253B1 (zh) |
JP (1) | JP6560673B2 (zh) |
KR (1) | KR20160044023A (zh) |
CN (2) | CN118271429A (zh) |
BR (1) | BR112016003196A8 (zh) |
CA (1) | CA2919174A1 (zh) |
HK (1) | HK1223108A1 (zh) |
MX (1) | MX2016001601A (zh) |
RU (1) | RU2652911C2 (zh) |
WO (1) | WO2015024896A1 (zh) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3268390A1 (en) * | 2015-03-13 | 2018-01-17 | NovImmune SA | Methods of purifying bispecific antibodies |
MA43987A (fr) * | 2015-05-12 | 2018-12-19 | Regeneron Pharma | Détermination de la pureté de protéine multimère |
CA2995385A1 (en) * | 2015-08-20 | 2017-02-23 | Genentech, Inc. | Purification of fkpa and uses thereof for producing recombinant polypeptides |
IL257146B1 (en) * | 2015-08-21 | 2024-09-01 | Hoffmann La Roche | A method for reducing host cell proteins in affinity chromatography |
WO2017032610A1 (en) * | 2015-08-21 | 2017-03-02 | F. Hoffmann-La Roche Ag | Affinity chromatography purification with low conductivity wash buffer |
US11186858B1 (en) | 2016-03-15 | 2021-11-30 | Fresenius Kabi Deutschland Gmbh | Methods for increasing biosimilarity |
KR20190039929A (ko) | 2016-06-17 | 2019-04-16 | 제넨테크, 인크. | 다중 특이적 항체의 정제 |
WO2018038469A1 (ko) * | 2016-08-20 | 2018-03-01 | (주)아이벤트러스 | 목적하는 이중특이성 항체의 선택적 생산 확인 방법 |
CN106800599B (zh) * | 2016-12-05 | 2021-03-23 | 中国人民解放军第二军医大学 | 抗人EGFR和Notch多特异性抗体、其制备方法及用途 |
EP3655429A1 (en) | 2017-07-21 | 2020-05-27 | Novimmune S.A. | Generating multispecific antibody mixtures and methods of uses thereof |
CN111491951B (zh) * | 2017-12-22 | 2024-05-24 | 豪夫迈·罗氏有限公司 | 通过疏水相互作用色谱法耗尽轻链错配的抗体变体 |
WO2019166932A1 (en) * | 2018-02-27 | 2019-09-06 | Pfizer Inc. | Antibody purification |
GB201805142D0 (en) * | 2018-03-29 | 2018-05-16 | Ge Healthcare Bioprocess R&D Ab | Separation method |
CN109517043B (zh) * | 2018-11-23 | 2022-06-14 | 艾美诚信生物制药有限公司 | 一种原核表达重组轮状病毒抗原p2-vp8的纯化方法 |
CN114409798A (zh) * | 2019-02-14 | 2022-04-29 | 美勒斯公司 | 制备包含两种或更多种抗体的组合物 |
US20220127375A1 (en) * | 2019-02-14 | 2022-04-28 | Merus N.V. | Producing compositions comprising two or more antibodies |
CN113281430A (zh) * | 2021-05-11 | 2021-08-20 | 苏州君盟生物医药科技有限公司 | 一种双特异性抗体的分离鉴定方法 |
CN116769044A (zh) * | 2023-07-11 | 2023-09-19 | 康日百奥生物科技(苏州)有限公司 | 抗cd3和cd19双特异性抗体蛋白及其层析纯化方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009092014A1 (en) | 2008-01-18 | 2009-07-23 | Gagnon Peter S | Enhanced purification of antibodies and antibody fragments by apatite chromatography |
AR075798A1 (es) | 2009-03-05 | 2011-04-27 | Abbott Lab | Proteinas de union a il-17 (interleuquina 17) |
AR080794A1 (es) * | 2010-03-26 | 2012-05-09 | Hoffmann La Roche | Anticuerpos bivalentes biespecificos anti- vegf/ anti-ang-2 |
AR080793A1 (es) | 2010-03-26 | 2012-05-09 | Roche Glycart Ag | Anticuerpos biespecificos |
US8895707B2 (en) * | 2010-08-18 | 2014-11-25 | Bio-Rad Laboratories, Inc. | Elution of proteins from hydroxyapatite resins without resin deterioration |
EP2686334B2 (en) * | 2011-03-16 | 2020-07-01 | F.Hoffmann-La Roche Ag | Ion exchange chromatography with improved selectivity for the separation of polypeptide monomers, aggregates and fragments by modulation of the mobile phase |
DK2768857T3 (da) * | 2011-10-19 | 2020-02-03 | Novimmune Sa | Fremgangsmåder til oprensning af antistoffer |
-
2014
- 2014-08-18 CN CN202410455212.2A patent/CN118271429A/zh active Pending
- 2014-08-18 CA CA2919174A patent/CA2919174A1/en not_active Abandoned
- 2014-08-18 MX MX2016001601A patent/MX2016001601A/es unknown
- 2014-08-18 BR BR112016003196A patent/BR112016003196A8/pt not_active Application Discontinuation
- 2014-08-18 CN CN201480045853.5A patent/CN105473612A/zh active Pending
- 2014-08-18 WO PCT/EP2014/067552 patent/WO2015024896A1/en active Application Filing
- 2014-08-18 EP EP14761965.4A patent/EP3036253B1/en active Active
- 2014-08-18 KR KR1020167007112A patent/KR20160044023A/ko not_active Application Discontinuation
- 2014-08-18 JP JP2016535445A patent/JP6560673B2/ja active Active
- 2014-08-18 RU RU2016109322A patent/RU2652911C2/ru active
-
2016
- 2016-02-19 US US15/048,308 patent/US10316059B2/en active Active
- 2016-09-27 HK HK16111307.7A patent/HK1223108A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
RU2016109322A (ru) | 2017-09-28 |
JP2016528268A (ja) | 2016-09-15 |
BR112016003196A8 (pt) | 2020-02-04 |
US10316059B2 (en) | 2019-06-11 |
JP6560673B2 (ja) | 2019-08-14 |
KR20160044023A (ko) | 2016-04-22 |
CA2919174A1 (en) | 2015-02-26 |
BR112016003196A2 (pt) | 2017-08-01 |
CN118271429A (zh) | 2024-07-02 |
CN105473612A (zh) | 2016-04-06 |
MX2016001601A (es) | 2016-05-02 |
US20160376304A1 (en) | 2016-12-29 |
EP3036253B1 (en) | 2020-09-23 |
RU2652911C2 (ru) | 2018-05-03 |
EP3036253A1 (en) | 2016-06-29 |
WO2015024896A1 (en) | 2015-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1223108A1 (zh) | 用羥基磷灰石層析分離雙特異性抗體和雙特異性抗體生產副產物 | |
IL291446A (en) | Anti-trop2 antibodies and methods for their production | |
HK1258304A1 (zh) | 優化抗cd3雙特異性抗體和其用途 | |
HK1211946A1 (zh) | 用於 的抗體構建體 | |
IL248007A0 (en) | Bispecific antibodies that bind to cd38 and cd3 | |
HK1203079A1 (zh) | 單鏈抗體及其他異多聚體 | |
EP3186279C0 (en) | ANTIBODY CONSTRUCTS FOR CDH19 AND CD3 | |
EP2970505A4 (en) | SPECIFIC ANTIBODIES AND USES THEREOF | |
IL240443A0 (en) | Antibodies against tnf-a with a high level of galactosylation and their uses | |
HK1223953A1 (zh) | 人源化的抗- 抗體和使用方法 | |
ZA201506568B (en) | Anti-tnf-anti-il-17 bispecific antibodies | |
EP2981286A4 (en) | ANTI-IL-4 ANTIBODIES AND BISPECIFIC ANTIBODIES AND USES THEREOF | |
ZA201509334B (en) | Improved process for production of monoclonal antibodies | |
GB201223276D0 (en) | Antibodies and methods of producing same | |
ZA201907065B (en) | Monoclonal antibody to pd-l1 | |
PL3019532T3 (pl) | Ludzkie bispecyficzne cząsteczki angażujące przeciwciało egfrviii | |
HK1216754A1 (zh) | 抗- 抗體及其使用方法 | |
EP2952895A4 (en) | PROCESS FOR PRODUCING A MARKED ANTIBODY | |
EP3080158A4 (en) | Polyclonal mixtures of antibodies, and methods of making and using them | |
GB201306706D0 (en) | Novel process for preparation of antibody conjugates and novel antibody conjugates |